+7 (701) 759 90 19
USD 432.64 EUR 505.02
RUB 5.47 CNY 64.7
News

About 66,000 coronavirus tests done in Moscow daily — mayor

19 September 2020 15:25
Share in:
About 66,000 coronavirus tests done in Moscow daily — mayor

MOSCOW. KAZINFORM - About 66,000 people are being tested for novel coronavirus in Moscow every day, Moscow Mayor Sergei Sobyanin told the Rossiya-1 TV channel, TASS reports.

Related news
Russia reports over 15,900 new COVID-19 cases

«First of all, it [the growth in novel coronavirus cases in Moscow] is linked to the increased number of tests made. The number of tests reaches 66,000 daily, which is a huge number. This means that we test about one million people every two weeks,» he said.

According to the mayor, the share of positive tests remains the same as 2-3 weeks ago.

«The number [of registered cases] grows because the overall number of tests also grows,» Sobyanin said.

He went on to say that the novel coronavirus sutaiton in Moscow is also affected by the season, the resumption of full-fledged business activities in the Russian capital and the start of the academic year.

«We need to do our best to prevent a seasonal flu epidemic this year. To that end, we have already vaccinated more than one million people, and at least five more million residents should be vaccinated. A total of 400 stationary and 50 mobile vaccination facilities are operational, this is enough so far, and there are no queues as of today,» the mayor said.

About 400 Moscow residents are to take part in post-registration trials of the novel coronavirus vaccine, Sobyanin said. The number of volunteers has already exceeded 60,000.

«A total of 700 people have already been vaccinated [against the novel coronavirus], all of them are feeling well,» the mayor said.

On August 11, Russia registered the world’s first vaccine against the novel coronavirus. The vaccine, dubbed Sputnik V, was developed by the Gamaleya National Research Center for Epidemiology and Microbiology of the Russian Health Ministry, and its clinical trials were successfully completed in June-July. The vaccine was developed on a platform that had been used for a number of other vaccines.



Share in:
+7
Send
Employees online
Editor
Nurmaganbetova Zhanna
Nurmaganbetova Zhanna
954-048
Editor
Kudrenok Tatyana
Kudrenok Tatyana
954-048
Editor
Seilkhanov Adlet
Seilkhanov Adlet
954-048

Archive